By: Ronan Dunne (Phillip Lee)
As a staunch Trump ally, former Attorney General Bill Barr will be remembered for a lot of things. His role in the redaction, and then subsequent disclosure, of the Mueller report and his interventions in cases involving Trump associates spring to mind. However, perhaps his legacy will be something entirely different, with wider ramifications for citizens across the globe, far beyond the Washington political bubble.
Under Barr’s watch, the US Department of Justice (DoJ) initiated a major lawsuit against Google in October for alleged violations of US competition law. Announcing the action, Barr said this was “a monumental case both for the Department of Justice and for the American people.”
The DoJ’s case has been taken in conjunction with 11 state Attorneys General (including the likes of Florida, Georgia and Texas). It is a civil antitrust lawsuit which alleges that Google has unlawfully maintained monopolies through anticompetitive practices in the search and search advertising markets.
The significance of the DoJ’s action cannot be underestimated. Google is one of the wealthiest corporations on the planet with a market value of over US$1 trillion. In announcing the action, Barr threw down the gauntlet to Google saying the “lawsuit strikes at the heart of Google’s grip over the internet for millions of American consumers, advertisers, small businesses and entrepreneurs beholden to an unlawful monopolist.” He compared the lawsuit with the historic antitrust actions taken against AT&T in 1974 and Microsoft in 1998…
Featured News
Top Antitrust Expert Joins Cravath from Paul Weiss
Jan 21, 2025 by
CPI
CMA Chief Removed as UK Government Targets Regulatory Overhaul
Jan 21, 2025 by
CPI
Court Denies Dismissal in Crab Price-Fixing Lawsuit
Jan 21, 2025 by
CPI
TikTok Stays Online for Now: Trump Floats US Ownership Deal
Jan 21, 2025 by
CPI
Hong Kong Watchdog Unveils Compliance Tool for Small Businesses
Jan 21, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Pharmacy Benefit Managers
Jan 20, 2025 by
CPI
Untangling the PBM Mess
Jan 20, 2025 by
Kent Bernard
Using Data, Not Anecdotes, to Analyze Criticisms of Pharmacy Benefit Managers
Jan 20, 2025 by
Dennis Carlton
Vertical Integration and PBMs: What, Me Worry?
Jan 20, 2025 by
Lawton Robert Burns & Bradley Fluegel
The Economics of Benefit Management in Prescription-Drug Markets
Jan 20, 2025 by
Casey B. Mulligan